Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What made it interesting to me

 

This is what intersted me more..;)

 

Riley Investment, which owns a 6.6 percent stake in Transmeta, had demanded a change in the company's board last December and expressed concern about the company's strategy following a favorable settlement of a patent litigation with Intel Corp (INTC.O: Quote, Profile, Research).

cheers

 

 

Share
New Message
Please login to post a reply